Ulcerative Colitis on Remicade

Time

PEB Forum Regular Member
Registered Member
Good Afternoon all, I am currently in the Med board process 05/20/23. I am being med boarded for Ulcerative Colitis with the use of biologics (remicade). I am about to enter the PEB portion and was wondering is it likely I’ll be unfit and what all the percentages could be like.
Thank you
 
I am on Remicade for Crohns, in the PEB phase and don't have my percentages yet, but was found unfit (Army).
 
unfit with a 10% VA and DOD rating, Currently going through the appeal process
The digestive system update for the VA Ratings were finally published. It is effective 19 May 2024. If you can appeal appeal appeal, and then get a VARR, it may bump you up. I recommend checking out your symptoms based on the new ratings, just in case you haven't yet.

7326 Crohn's disease or undifferentiated form of inflammatory bowel disease:

Severe inflammatory bowel disease that is unresponsive to treatment; and requires hospitalization at least once per year; and results in either an inability to work or is characterized by recurrent abdominal pain associated with at least two of the following: (1) six or more episodes per day of diarrhea, (2) six or more episodes per day of rectal bleeding, (3) recurrent episodes of rectal incontinence, or (4) recurrent abdominal distension 100

Moderate inflammatory bowel disease that is managed on an outpatient basis with immunosuppressants or other biologic agents; and is characterized by recurrent abdominal pain, four to five daily episodes of diarrhea; and intermittent signs of toxicity such as fever, tachycardia, or anemia 60

Mild to moderate inflammatory bowel disease that is managed with oral and topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and minimal signs of toxicity such as fever, tachycardia, or anemia 30

Minimal to mild symptomatic inflammatory bowel disease that is managed with oral or topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and no signs of systemic toxicity 10



 
Top